HRCT
Qureight paper argues for fibrosis extent as imaging biomarker in lung disease trials
November 11, 2026Chronic Diseases, HRCT, biomarkers, idiopathic pulmonary fibrosis, respiratory illness
Qureight has published a peer-reviewed paper arguing that the extent of pulmonary fibrosis should be considered the principal structural imaging …
